Latest! Beijing Health and Safety Commission notice: hospital examination began.

Pharmaceutical Network August 27th, recently, the Beijing Municipal Health and Safety Commission issued "on the development of the medical industry style construction work special action notice."
, according to the notice, the special operation will be implemented in three steps, of which, the focus on publicity and rectification time is September-November 2020.
, there is less than a week to go, Beijing Hospital will officially open! In the task of special action, there are two aspects worthy of medical attention: 1, check the red envelope focus on checking all kinds of medical institutions at all levels practitioners (including doctors, nurses, medical technicians, administrative personnel) to take advantage of the convenience of their duties, in medical activities (including the introduction of hospitalization, examination, treatment, surgery and other links) to obtain or receive patients and their families in various names to give gifts of "red envelope" gifts or other improper benefits of illegal acts, according to the seriousness of the violation.
2, check rebates, check the party, check the promotion of key checks and combat the following acts: 1) medical institutions practitioners accept medicines, medical equipment, medical hygiene materials and other pharmaceutical products production, operating enterprises or distribution personnel in various names and forms of rebate behavior; Such as the collection of commission behavior; 4) medical institutions and their employees in violation of regulations to publish medical advertisements, participate in pharmaceutical products, food, health care products and other commodity marketing activities; 5) medical personnel use any way and means for commercial purposes to statistics physicians and clinical departments related to the amount of drugs, medical supplies information, to facilitate the statistics of pharmaceutical marketing personnel, 6) medical personnel in violation of regulations to purchase, sell, use drugs, medical equipment, medical hygiene materials and other medical products.
3. Medical representative medical institutions shall make full use of artificial intelligence or information technology to provide early warning, monitoring and timely treatment of the marketing practices of distribution personnel of pharmaceutical products production and operation enterprises entering the medical institutions and engaging with medical personnel.
to examine medical institutions outpatient clinics, inpatient departments, pharmacies and other areas of the production of pharmaceutical products, operating enterprises or distribution personnel illegal sales of drugs, medical equipment to medical personnel, business negotiations.
Beijing Health and Health Commission requires that the district health and health committees should identify specialized agencies and personnel, specifically responsible for the "red envelope", rebate reporting and acceptance work, to strengthen the drug circulation, bidding, procurement, clinical use and other aspects of comprehensive governance, the establishment of pharmaceutical purchase and sale of bad records of commercial bribery, in accordance with the provisions of the drug, medical equipment and medical supplies production, operating enterprises in accordance with the law, guide and restrain relevant industry enterprises and practitioners to comply with the relevant laws and regulations.
According to the "Notice on the Issuance of the Special Action Plan for the Construction of Style in the Medical Industry in 2020" issued by the General Office of the National Health and Safety Commission on July 24, it is clear that from July this year until the end of the year, the focus will be on the treatment of medical personnel to collect kickbacks, pharmaceutical companies illegal marketing and other acts.
addition to Beijing, the current to all parts of the country have also responded, quickly introduced a plan of action.
Liaoning Provincial Health And Wellness Commission made it clear that between now and June 2022, a new round of inspections will be conducted on hospitals, focusing on the four aspects of party building, industry style construction, operation and management, and the characteristics of Chinese medicine hospitals, especially the implementation of the "nine not allowed" medical and health practice construction.
, the Implementation Plan for the Inspection of Large Hospitals in Liaoning Province (2020-2022) has been issued, and the current round of inspections will be carried out in a planned and step-by-step way.
Shaanxi Provincial Health And Wellness Commission recently issued the "2020 provincial health and health industry style of special corrective action plan" also clearly, to carry out the industry association special governance action, in-depth clean up the masses around the medical industry chaos, serious investigation and punishment of the collection of pharmaceutical supplies enterprise rebate behavior, and by the end of August 2020 a comprehensive inventory, centralized rectification.
large number of pharmaceutical companies, pay attention to the hospital is undergoing major rectification at the same time, pharmaceutical companies should also be vigilant.
is the so-called medicine does not know the family, if found "medical" problem, "drug" must also not escape.
this year, the state's crackdown on the pharmaceutical industry with gold sales, commercial bribery efforts are also escalating.
January 10, 2020 National Conference on Medical Management held, proposed this year to "establish a clean style of the industry hard work."
On June 5, the National Health and Safety Commission and nine other departments issued a notice on "2020 to correct the wrong wind in the field of pharmaceutical purchase and sale and in medical services" clearly proposed to carry out special management against medical institutions practitioners to receive rebates, focusing on the inspection of medical institutions practitioners to accept medicines, medical equipment, medical hygiene materials and other pharmaceutical products production, operating enterprises or distribution personnel in various names, forms of rebate behavior.
, once the facts of kickbacks are confirmed, in addition to medical personnel will be dealt with seriously in accordance with the law, the business operators involved in the case will also be subject to penalties including the publicity of credit information.
July 24, the State Health Insurance Administration issued the Guidance on the Establishment of a Drug Price and Recruitment Credit Evaluation System (Draft for Comments), which clearly stipulates that pharmaceutical enterprises undertake to bear joint and joint price and credit disciplinary responsibilities for commercial bribery and market manipulation of drugs committed by entrusting service enterprises and agency enterprises for their own medicines.
some of the drug-for-personal behavior, the responsibility for bribery will be completely "dumped" opportonism, will no longer exist.
addition, the newly amended Drug Administration Act has increased industry bans on commercial bribery.
we can also feel the unprecedented strength of the state in the fight against medical corruption.
in a new policy environment, for all pharmaceutical companies, if there is any non-compliance, is undoubtedly a lightning step, a little careless will be directly out.
.